CN1094058A - 缓激肽拮抗剂 - Google Patents

缓激肽拮抗剂 Download PDF

Info

Publication number
CN1094058A
CN1094058A CN93114484A CN93114484A CN1094058A CN 1094058 A CN1094058 A CN 1094058A CN 93114484 A CN93114484 A CN 93114484A CN 93114484 A CN93114484 A CN 93114484A CN 1094058 A CN1094058 A CN 1094058A
Authority
CN
China
Prior art keywords
dipolymer
heterogeneous
group
bka
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN93114484A
Other languages
English (en)
Chinese (zh)
Inventor
J·C·彻奥尼斯
J·K·博劳德格特
V·S·古德佛楼
M·V·马拉瑟
L·W·思普鲁斯
E·T·瓦雷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cortech Inc
Original Assignee
Cortech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortech Inc filed Critical Cortech Inc
Publication of CN1094058A publication Critical patent/CN1094058A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN93114484A 1992-11-10 1993-11-10 缓激肽拮抗剂 Pending CN1094058A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97400092A 1992-11-10 1992-11-10
US07/974,000 1992-11-10

Publications (1)

Publication Number Publication Date
CN1094058A true CN1094058A (zh) 1994-10-26

Family

ID=25521455

Family Applications (1)

Application Number Title Priority Date Filing Date
CN93114484A Pending CN1094058A (zh) 1992-11-10 1993-11-10 缓激肽拮抗剂

Country Status (11)

Country Link
EP (1) EP0671941A4 (fr)
JP (1) JPH08503460A (fr)
CN (1) CN1094058A (fr)
AU (1) AU5410994A (fr)
CA (1) CA2147869A1 (fr)
IL (1) IL107400A0 (fr)
MX (1) MX9306988A (fr)
NZ (1) NZ257477A (fr)
PL (1) PL304654A1 (fr)
WO (1) WO1994011021A1 (fr)
ZA (1) ZA938014B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0663401B1 (fr) * 1993-07-23 2000-06-07 Toray Industries, Inc. Derive de morphinane et application medicale
EP0832106A2 (fr) * 1995-06-05 1998-04-01 Cortech, Inc. Composes ayant une activite antagoniste de la bradykinine et une activite agoniste mu-opio de
US6143719A (en) * 1995-06-09 2000-11-07 The Regents Of The University Of Michigan Bradykinin analogs as selective thrombin inhibitors
FR2739553B1 (fr) 1995-10-06 1998-01-02 Oreal Utilisation d'antagonistes de la bradykinine pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
DE19612067A1 (de) * 1996-03-27 1997-10-02 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen
DE19642289A1 (de) 1996-10-14 1998-04-16 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung und Prävention der Alzheimer'schen Krankheit
US6982249B1 (en) 1997-04-23 2006-01-03 The Regents Of The University Of Michigan Bradykinin analogs as selective inhibitors of cell activation
US6359111B1 (en) * 1998-05-28 2002-03-19 Neorx Corporation Opioid receptor targeting
US7060708B2 (en) 1999-03-10 2006-06-13 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US6716452B1 (en) 2000-08-22 2004-04-06 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
EP2080511A3 (fr) * 2000-08-22 2009-09-30 Shire LLC Systèmes d'administration de principe actif et procédé pour la protection et l'administration de principes actifs
WO2005032474A2 (fr) 2003-09-30 2005-04-14 New River Pharmaceuticals Inc. Compositions pharmaceutiques pour prevenir une dose excessive ou un abus
WO2003020200A2 (fr) 2000-11-16 2003-03-13 New River Pharmaceuticals Inc. Nouveau compose pharmaceutique et procedes de fabrication et d'utilisation de ce compose
EP1357928B1 (fr) * 2000-11-16 2011-11-16 Shire LLC Nouveau composé pharmaceutique et procédés de fabrication et d'utilisation de ce composé
AU2001297565B2 (en) * 2000-11-16 2008-06-05 Takeda Pharmaceutical Company Limited A novel pharmaceutical compound and methods of making and using same
US7169752B2 (en) 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US7338939B2 (en) 2003-09-30 2008-03-04 New River Pharmaceuticals Inc. Abuse-resistant hydrocodone compounds
US7375082B2 (en) 2002-02-22 2008-05-20 Shire Llc Abuse-resistant hydrocodone compounds
US7700561B2 (en) 2002-02-22 2010-04-20 Shire Llc Abuse-resistant amphetamine prodrugs
AU2003219863C1 (en) 2002-02-22 2009-03-05 Shire Llc Novel sustained release pharmaceutical compounds to prevent abuse of controlled substances
AR040956A1 (es) 2002-07-31 2005-04-27 Schering Ag Nuevos conjugados de efectores, procedimientos para su preparacion y su uso farmaceutico
AU2003253365A1 (en) * 2002-07-31 2004-02-23 Schering Ag New effector conjugates, process for their production and their pharmaceutical use
GB0624880D0 (en) * 2006-12-14 2007-01-24 Johnson Matthey Plc Improved method for making analgesics

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894443A (en) * 1984-02-08 1990-01-16 Cetus Corporation Toxin conjugates
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
WO1992017201A1 (fr) * 1991-04-01 1992-10-15 Cortech, Inc. Antagonistes de la bradykinine
SE9101472D0 (sv) * 1991-05-15 1991-05-15 Trion Forskning & Utveckling Galanin antagonist

Also Published As

Publication number Publication date
EP0671941A1 (fr) 1995-09-20
AU5410994A (en) 1994-06-08
CA2147869A1 (fr) 1994-05-26
ZA938014B (en) 1994-07-11
MX9306988A (es) 1995-01-31
EP0671941A4 (fr) 1996-05-29
NZ257477A (en) 1996-07-26
WO1994011021A1 (fr) 1994-05-26
IL107400A0 (en) 1994-01-25
JPH08503460A (ja) 1996-04-16
PL304654A1 (en) 1995-01-09

Similar Documents

Publication Publication Date Title
CN1094058A (zh) 缓激肽拮抗剂
CN1129606C (zh) 七肽催产素类似物
DE69623254T2 (de) Lhrh antagonistische peptide
US7098307B2 (en) Neo-tryptophan
US5440013A (en) Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
US5863899A (en) Bradykinin antagonists
JP3762407B2 (ja) 糖尿病を治療又は予防するためのジペプチジルペプチダーゼ阻害薬としてのβ−アミノテトラヒドロイミダゾ（１，２−Ａ）ピラジン類及びテトラヒドロトリアゾロ（４，３−Ａ）ピラジン類
CN1035006C (zh) 具有缓激肽拮抗剂作用的肽类的制备方法
US5620958A (en) Bradykinin antagonists
CN1309711C (zh) 3－酰氨基－1,2－苯并异噁唑衍生物、其制备方法及应用
JP2006525276A (ja) グルタミニルシクラーゼ阻害剤
CN1133047A (zh) 治疗用肽衍生物
US5416191A (en) Bradykinin antagonists
CN1882534A (zh) N－[苯基(2－吡咯烷基)甲基]苯甲酰胺和n－[(2－氮杂环庚烷基)苯基甲基]苯甲酰胺衍生物,其制备和治疗用途
CN1295558A (zh) 新的局部麻醉化合物及用途
DE69528531T2 (de) D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet
CN1347325A (zh) 用作生长激素促分泌剂的新酰胺衍生物
CN1227259C (zh) 用于治疗脂代谢紊乱的与胆汁酸相连的丙醇胺类衍生物
JPH0692366B2 (ja) 非ペプチド性レニン阻害剤
CN1056615C (zh) 二氟五肽衍生物消炎剂
EP1444194B1 (fr) N-methylhomocysteines, leur utilisation et leur procede de production
TW201000096A (en) Four-membered ring-condensed pyrrolidine derivatives, and preparation method and medical use thereof
CN1039017A (zh) 新化合物的制备方法
JP2003335798A (ja) 新規なペプチド及びその医薬的用途
Gardiner Conformationally restricted amino acid analogues based on lactams

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication